LucidQuest Our Work Competitive Intelligence

How we helped a CNS mid-size pharma understand a new competitor in the EU after researching its sales force. 

The Challenge: Assessing the impact of a new competitive entry in the CNS space…


LucidQuest Case Study Hematology

How a large pharma in Hematology and Oncology space established and used competitive benchmarks across the US

The Challenge: Knowing field force performance against the competition  A large…


LucidQuest Our Work Competitive Intelligence

How a leading global player in the respiratory space worked towards speedier access to Russia and China

The Challenge: Leading multinational Pharma company wants to dive deep into key…


Biopharma CVC portfolios 2023

Do you want to gain insights into the CVC portfolios of 19 Biopharma Companies and Google? Then read below!

Over the past few years, corporate venture capital (CVC) companies backed by or…


Gene Therapy for IRDs

Gene therapy treatments for Inherited Retinal Disorders (IRD) hold great promise. 

Globally 4.5 million people are affected by IRDs — a group of diseases having a…


AAV challenges. Liver Toxicity. Tumorigenesis.

AAV-based gene therapies: Safe or not? Challenges and considerations for the future.

Adeno-associated virus (AAV) is one of the most studied gene therapy vehicles.…


Decentralized Clinical Trials (DCTs) in Oncology

Decentralized Clinical Trials (DCTs) in Oncology – Is the Pharma Industry ready?

The acceptance of telehealth and the incorporation of digital technologies have…


Human figure in black background for article on Metaverse and Healthcare

Metaverse and Healthcare: prepare to enter the Matrix!

No matter how hard it is to believe, we see a concept from a sci-fi movie…


Abstract painting accompanying hemophilia management trends blogpost

Emerging trends in Hemophilia management. Is it time to say goodbye to standard CFC replacement therapy?

What is hemophilia? Hemophilia is a rare X-linked congenital bleeding disorder.…